Boston Scientific Announces Results For Second Quarter 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Boston Scientific (BSX) PT Raised to $47 at Cowen
July 24, 2019 3:34 PM EDTCowen analyst Joshua Jennings raised the price target on Boston Scientific (NYSE: BSX) to $47.00 (from $42.00) while maintaining an Outperform rating.
The analyst commented, "While 2Q organic revenue growth of 6.3% was below the midpoint of guidance for 6%-7%, BSX has a steady flow... More
Boston Scientific (BSX) Tops Q2 EPS by 1c
July 24, 2019 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q2 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $2.63 billion versus the consensus estimate of $2.64 billion.
GUIDANCE:
Boston Scientific sees Q3 2019 EPS of $0.37-$0.39, versus the consensus of... More
